Jubilant Life Sciences has appointed Gurpartap Singh Sachdeva has been appointed as the Chief Executive Officer, Jubilant Pharma, a 100 per cent wholly-owned subsidiary of Jubilant Life Sciences. Singh will have overall responsibility for the operations under Jubilant Pharma and will report to the Jubilant Pharma Board. He will be based in the US.
Shyam S Bhartia, Chairman and Managing Director and Hari S Bhartia, Co-Chairman and Managing Director, Jubilant Life Sciences said, “We are pleased to welcome Singh into the Jubilant family to complete our pharma consolidation. Our pharma segment has attained significant scale and the businesses therein have great potential for growth. Singh’s rich experience in pharma industry will help the company to enhance its focus and competitiveness thereby unlocking shareholder value.”